[ACRS] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
25-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 66.39%
YoY- 51.77%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 1,449 2,046 1,407 1,095 983 5,865 5,041 -56.34%
PBT -10,659 -11,570 -15,328 -19,177 -23,138 -49,876 -37,565 -56.72%
Tax -591 27 -318 -32,181 32,733 18,504 0 -
NP -10,659 -11,597 -15,586 -18,594 -55,319 -49,876 -37,565 -56.72%
Tax Rate - - - - - - - -
Total Cost 12,108 13,643 16,993 19,689 56,302 55,741 42,606 -56.67%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -735.61 -566.81 -1,107.75 -1,698.08 -5,627.57 -850.40 -745.19 -0.85%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.25 -0.28 -0.37 -0.45 -1.34 -1.21 -0.91 -57.64%
EPS Diluted -0.25 -0.28 -0.37 -0.45 -1.34 -1.21 -0.91 -57.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.